Completed PHASE4 INTERVENTIONAL NCT00402571

Hepatic Function During and Following Three Days of Acetaminophen Dosing in Alcoholics

Assessment of Hepatic Function in Alcoholic Patients Administered Therapeutic Dosing of Acetaminophen- a Multicenter Study

Sponsor: Denver Health and Hospital Authority

Conditions Alcohol Related Disorders

Interventions acetaminophen

Updated 5 times since 2017 Last updated: Feb 6, 2009 Started: Jan 31, 2002 Completion: Jul 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Alcohol Related Disorders, this trial is completed. The trial is conducted by Denver Health and Hospital Authority and has accumulated 5 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Denver Health and Hospital Authority
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Data source: Denver Health and Hospital Authority

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Denver, United States
• Seattle, United States